Detalhe da pesquisa
1.
Interfaces between cellular responses to DNA damage and cancer immunotherapy.
Genes Dev
; 35(9-10): 602-618, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888558
2.
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.
Clin Cancer Res
; 30(7): 1338-1351, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967136
3.
USP7 and VCPFAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork.
Cell Rep
; 37(2): 109819, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644576
4.
SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication.
Nat Commun
; 10(1): 3142, 2019 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316063
5.
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks.
Nat Commun
; 10(1): 87, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30622252
6.
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
Nat Cell Biol
; 20(8): 954-965, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022119
7.
Chromatin-associated degradation is defined by UBXN-3/FAF1 to safeguard DNA replication fork progression.
Nat Commun
; 7: 10612, 2016 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26842564
8.
Erratum: Chromatin-associated degradation is defined by UBXN-3/FAF1 to safeguard DNA replication fork progression.
Nat Commun
; 7: 11593, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27186651